CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression.
CHD7 is one of nine members of the chromodomain helicase DNA-binding domain family of ATP-dependent chromatin remodeling enzymes found in mammalian cells. De novo mutation of CHD7 is a major cause of CHARGE syndrome, a genetic condition characterized by multiple congenital anomalies. To gain insight...
Main Authors: | Michael P Schnetz, Lusy Handoko, Batool Akhtar-Zaidi, Cynthia F Bartels, C Filipe Pereira, Amanda G Fisher, David J Adams, Paul Flicek, Gregory E Crawford, Thomas Laframboise, Paul Tesar, Chia-Lin Wei, Peter C Scacheri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-07-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC2904778?pdf=render |
Similar Items
-
Otitis media in a new mouse model for CHARGE syndrome with a deletion in the Chd7 gene.
by: Cong Tian, et al.
Published: (2012-01-01) -
CHD7 gene polymorphisms in female patients with idiopathic scoliosis
by: Karolina Borysiak, et al.
Published: (2020-01-01) -
Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes.
by: Engelen, E, et al.
Published: (2011) -
Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes
by: Engelen, E, et al.
Published: (2011) -
Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy
by: Weixing Feng, et al.
Published: (2022-06-01)